Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Erazaban

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,250Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Dr Reddys’s Generics Docosanol Receives Approval in US
    Dr Reddys’s Generics Docosanol Receives Approval in US

    23 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215505

    FDA
    23 Oct 2025
    Share Share
    Dr Reddys’s Generics Docosanol Receives Approval in US
    Dr Reddys’s Generics Docosanol Receives Approval in US

    03 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214613

    FDA
    03 Oct 2025
    Share Share
    Encube's Generic Docosanol Receives Approval in the U.S.
    Encube's Generic Docosanol Receives Approval in the U.S.

    07 Oct 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212385

    FDA
    07 Oct 2022
    Share Share
    Cosette Pharma, Alembic Pharma Announce the Approval and Launch of NBE of Abreva
    Cosette Pharma, Alembic Pharma Announce the Approval and Launch of NBE of Abreva

    24 May 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220524005173/en

    BUSINESSWIRE
    24 May 2022
    Share Share
    Aleor Dermaceuticals receives final USFDA approval for cold sore drug
    Aleor Dermaceuticals receives final USFDA approval for cold sore drug

    04 May 2022

    // ET HEALTH

    https://health.economictimes.indiatimes.com/news/pharma/aleor-dermaceuticals-receives-final-usfda-approval-for-cold-sore-drug/91309474

    ET HEALTH
    04 May 2022
    Share Share
    Actavis Labs' Generic Docosanol Receives Approval in US
    Actavis Labs' Generic Docosanol Receives Approval in US

    21 Nov 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208754

    FDA
    21 Nov 2018
    Share Share